|Bid||1.9200 x 1100|
|Ask||2.1500 x 2200|
|Day's range||1.9000 - 1.9800|
|52-week range||1.5400 - 8.8200|
|Beta (5Y monthly)||0.05|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2023 - 13 Nov 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.80|
Key Insights Significantly high institutional ownership implies Poseida Therapeutics' stock price is sensitive to their...
Poseida Therapeutics, Inc. ( NASDAQ:PSTX ) shareholders will have a reason to smile today, with the analysts making...
Poseida Therapeutics, Inc. (PSTX) delivered earnings and revenue surprises of 39.62% and 100.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?